Form 485BXT Elevation Series Trust
As filed with the Securities and Exchange Commission on September 28, 2026
Securities Act Registration No. 333-265972
Investment Company Act Registration No. 811-23812
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
| ☐ | Pre-Effective Amendment No. __ |
| ☒ | Post-Effective Amendment No. 105 |
and/or
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940
| ☒ | Amendment No. 106 |
Elevation Series Trust
(Exact Name of Registrant as Specified in Charter)
1700 Broadway, Suite 2100
Denver, CO 80290
(Address of Principal Executive Offices)
Registrant’s Telephone Number, including Area Code: 303-226-4150
Anne Berg
Elevation Series Trust
1700 Broadway, Suite 2100
Denver, CO 80290
The Corporation Trust Company
1209 Orange Street
Wilmington, DE 19801
(Name and address of agent for service)
With copy to:
JoAnn M. Strasser
Thompson Hine LLP
17th Floor
41 South High Street
Columbus, Ohio 43215
It is proposed that this filing will become effective:
| ☐ | Immediately upon filing pursuant to paragraph (b) | |
| ☒ | On October 6, 2026, pursuant to paragraph (b) | |
| ☐ | 60 days after filing pursuant to paragraph (a)(1) | |
| ☐ | On (date) pursuant to paragraph (a)(1) | |
| ☐ | 75 days after filing pursuant to paragraph (a)(2) | |
| ☐ | On (date) pursuant to paragraph (a)(2) of Rule 485. |
If appropriate, check the following box:
| ☒ | This post-effective amendment designates a new effective date for a previously filed post-effective amendment. |
The sole purpose of this filing is to delay the effectiveness of the Trust’s Post-Effective Amendment No. 102 to its Registration Statement until October 6, 2026. Post-Effective Amendment No. 102 to the Trust’s Registration Statement relates to the Clough Global Macro ETF. Parts A, B and C of Registrant’s Post-Effective Amendment No. 102 under the Securities Act of 1933 and Amendment No. 103 under the Investment Company Act of 1940, filed on July 16, 2026, are incorporated by reference herein.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets all of the requirements for effectiveness of this registration statement under rule 485(b) under the Securities Act of 1933 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, duly authorized, in the City of Denver and the State of Colorado, on the 28th day of September, 2026.
| ELEVATION SERIES TRUST | |||
| By: | /s/ Bradley Swenson | ||
| Bradley Swenson | |||
| President | |||
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the date indicated.
| Signature | Title | Date | ||
| /s/ Bradley Swenson | ||||
|
Bradley Swenson |
President, Principal Executive Officer and Trustee |
September 28, 2026 | ||
| /s/ Nicholas Austin | ||||
|
Nicholas Austin |
Treasurer and Principal Financial Officer (Principal Accounting Officer) | September 28, 2026 | ||
| Steven Norgaard* | ||||
|
Steven Norgaard
|
Trustee | September 28, 2026 | ||
| Kimberly Storms* | ||||
|
Kimberly Stoms |
Trustee
|
September 28, 2026 | ||
| Corey Dillon* | ||||
|
Corey Dillon |
Trustee
|
September 28, 2026
|
| *By: | /s/ Anne Berg | ||
| Name: | Anne Berg | ||
| Title: | Attorney-in-fact | ||
| Date: | September 28, 2026 |
| * | Attorney-in-Fact – pursuant to Powers of Attorney as previously filed on June 10, 2025. |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- University of Phoenix announces 2026 Faculty of the Year award recipients
- Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency
- TempraMed Announces Upsize to Offering
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share